PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 52 |
| PubMedID- 24933975 | [efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome]. |
| PubMedID- 26399788 | Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver. |
| PubMedID- 22824914 | In patients with metabolic syndrome, the prevalence of non-alcoholic fatty liver disease (nafld) is two- or three time higher than in general population (marchesini et al., 2003). |
| PubMedID- 21212755 | Nonalcoholic fatty liver disease is associated with the metabolic syndrome. |
| PubMedID- 22644007 | Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome. |
| PubMedID- 23962027 | High ggt may be a marker of non-alcoholic fatty liver disease, which is associated with the metabolic syndrome. |
| PubMedID- 21118396 | Background: moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome. |
| PubMedID- 23842720 | Non-alcoholic steatohepatitis (nash) is the progressive phenotype of non-alcoholic fatty liver disease associated with the metabolic syndrome. |
| PubMedID- 23032980 | Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults. |
| PubMedID- 25947379 | Non-alcoholic fatty liver disease is associated with metabolic syndrome and is becoming one of the most common forms of liver disease worldwide. |
| PubMedID- 22808787 | The aim of review: to verify the role of nutrition in development of nonalcoholic fatty liver disease in patients with metabolic syndrome. |
| PubMedID- 24834224 | The mean body mass index of the 22 cases was 31.18 ±5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects. |
| PubMedID- 24000461 | [strengthen the research and management of the relationship of liver diseases with metabolic syndrome]. |
| PubMedID- 21698231 | Non-alcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, a cluster of factors associated with the development of insulin resistance and atherosclerosis which has reached epidemic proportions in the developed world [1]. |
| PubMedID- 24748893 | Fatty liver disease is often associated with the metabolic syndrome defined as hyperinsulinemia or a fasting blood glucose level > 100 mg/dl or a blood glucose level > 200 mg/dl 2h after an oral glucose tolerance test plus either obesity, dyslipidemia or hypertension (4, 5). |
| PubMedID- 22546752 | Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. |
| PubMedID- 21387764 | [non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus. |
| PubMedID- 23935723 | Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. |
| PubMedID- 21040936 | The metabolic syndrome is associated with nonalcoholic fatty liver disease (nafld) as well as with insulin resistance, inflammatory adipokines, endothelial dysfunction, and higher plasma levels of nonesterified fatty acids (nefa), all of which may also affect the development of nafld. |
| PubMedID- 20814441 | Nonalcoholic fatty liver disease (nafld) is associated with metabolic syndrome and insulin resistance [58]. |
| PubMedID- 25960770 | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 24424211 | Non-alcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, especially obesity, hyperlipidaemia and diabetes1, and is now the most common liver disease in both adults and children worldwide2. |
| PubMedID- 22135029 | It is important to analyse the morphologic spectrum of bile duct changes in non-biliary diseases as a link has been reported between intrahepatic cholangiocarcinoma and chronic liver disease associated with viral hepatitis, metabolic syndromes and with alcohol abuse. |
| PubMedID- 24765691 | An association of non-alcoholic fatty liver disease with insulin resistant metabolic syndrome and hypothyroidism has been suggested. |
| PubMedID- 26117210 | Objective: in patients with familial combined hyperlipidemia (fchl), without metabolic syndrome (ms), occurrence of non-alcoholic fatty liver disease (nafld) is related to a specific pro-inflammatory profile, influenced by genetic traits, involved in oxidative stress and adipokine secretion. |
| PubMedID- 20645852 | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. |
| PubMedID- 22844333 | Nonalcoholic fatty liver disease is associated with metabolic syndrome. |
| PubMedID- 22884916 | Background: nonalcoholic fatty liver disease is closely associated with metabolic syndrome and cardiovascular disease (cvd). |
| PubMedID- 22824769 | The study therefore highlights the need to educate physicians on how to diagnose cirrhosis non-invasively and correlate features of metabolic syndrome with chronic liver disease. |
| PubMedID- 23897104 | Background: the association of plasma cardiovascular risk markers and metabolic syndrome (mets) with non-alcoholic fatty liver disease (nafld) has not been well defined. |
| PubMedID- 25911912 | The aim of the study was to evaluate the main features of the gastrointestinal myoelectrical activity (gi mea) in patients with nonalcoholic fatty liver disease (nafld) associated with metabolic syndrome (ms). |
| PubMedID- 24665862 | Management of fatty liver disease with the metabolic syndrome. |
| PubMedID- 21330637 | Nonalcoholic fatty liver disease (nafld) occurs in patients with components of metabolic syndrome. |
| PubMedID- 25988570 | Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 24044566 | Serum adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease. |
| PubMedID- 21760736 | Bio f(1)b hamsters fed with a high-fat/high-cholesterol diet may thus be a good animal model for research on the treatment of diet-induced metabolic syndrome complicated by nonalcoholic fatty liver disease. |
| PubMedID- 22813407 | Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population. |
| PubMedID- 25926979 | The presence of multiple features of the metabolic syndrome is associated with progressive liver disease [53]. |
| PubMedID- 23419204 | Objective: while nonalcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, it is not known if nafld plays an independent role in the atherogenic dyslipidemia phenotype. |
| PubMedID- 24850609 | [effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity]. |
| PubMedID- 21413092 | Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies. |
| PubMedID- 23227347 | Nonalcoholic fatty liver disease is closely associated with features of metabolic syndrome and likely represents the hepatic manifestation of the metabolic syndrome. |
| PubMedID- 25430922 | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. |
| PubMedID- 23077931 | The central role of the non alcoholic fatty liver disease in metabolic syndrome. |
| PubMedID- 24531850 | Evolving information suggests that the metabolic syndrome with non-alcoholic liver disease may be an important cause of hcc in addition to viral hepatitis and alcohol-induced liver disease. |
| PubMedID- 22103753 | Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. |
| PubMedID- 26120587 | Nonalcoholic fatty liver disease relationship with metabolic syndrome in class iii obesity individuals. |
| PubMedID- 24793377 | In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro. |
| PubMedID- 26088821 | In metabolic syndrome, the development of nonalcoholic fatty liver disease (nafld) is known. |
| PubMedID- 24713801 | Background: although non-alcoholic fatty liver disease (nafld) is associated with obesity and metabolic syndrome (ms), it may also be present in lean individuals. |
Page: 1 2